Healthcare & Life Sciences
Replace Therapeutics
stubseries-c-plus
series-c-plus
Stage
2023
Founded
2
Investors
About
Less than a month after launching with $213 million in funding, gene editing company Tome Biosciences has acquired a tiny Californian startup called Replace Therapeutics to expand ...
Explore Replace Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.